Introduction

Category: Novel Psychoactive Substances (page 7)

Category: Novel Psychoactive Substances (page 7)

The Industry’s Role in Responding to the Opioid Crisis

← Back to Series  Overview This webinar will describe the role that the reference material manufacturer plays by providing the tools needed to respond to the current opioid epidemic. Whether by rapidly providing authentic reference standards of novel emerging drugs…
Continue reading “The Industry’s Role in Responding to the Opioid Crisis”…

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

Date April 2017 Overview Novel psychoactive substances (NPS) represent significant analytical and interpretive challenges to forensic and clinical toxicologists. Timely access to case reports and reports of adverse incidents of impairment or toxicity is imperative to clinical diagnosis and treatment,…
Continue reading “Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review”…

2016 National Institute of Justice Forensic Science Research and Development Symposium

Date July 2016 Overview The 2016 NIJ Research and Development Symposium is intended to promote collaboration and enhance knowledge transfer of NIJ-funded research. The NIJ Research and Development (R&D) Program funds both basic or applied R&D projects that will (1)…
Continue reading “2016 National Institute of Justice Forensic Science Research and Development Symposium”…